Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06151600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J

Study acronym: CMT4J
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    v5
  2. Primary completion date: Mar 1, 2027 to Mar 1, 2031
    • Study completion date: Mar 1, 2028 to Mar 1, 2032
    v4
  3. Study sites: 1 to 3v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2024 to Jul 29, 2024
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, longitudinal, prospective observational natural history study of subjects with a molecularly confirmed diagnosis of CMT4J. The study will enroll 20 subjects of any age into a uniform protocol for follow-up and evaluations. Subject visits will occur every 12 months + 4 weeks for up to 2 years.
Trial Details
NCT Number NCT06151600
Lead Sponsor Elpida Therapeutics SPC
Conditions
(from sponsor)		 Peripheral Neuropathy, Neuro-Degenerative Disease, Neuromuscular Diseases
Related terms Neuromuscular Diseases, Peripheral Nervous System Diseases
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov